{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:12:04Z","timestamp":1777623124294,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2022-NR067269"],"award-info":[{"award-number":["2022-NR067269"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015098","name":"Seoul National University Seoul Metropolitan Government Boramae Medical Center","doi-asserted-by":"publisher","award":["04-2023-0032 & 0033"],"award-info":[{"award-number":["04-2023-0032 & 0033"]}],"id":[{"id":"10.13039\/501100015098","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.cbi.2025.111867","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T07:34:34Z","timestamp":1765265674000},"page":"111867","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Inhibition of NOD-like receptor pyrin domain-containing protein 3 inflammasome activation by MK-571, a multidrug resistance protein inhibitor"],"prefix":"10.1016","volume":"424","author":[{"given":"Seungseok","family":"Oh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeongwoo","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2926-1007","authenticated-orcid":false,"given":"Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2867-8940","authenticated-orcid":false,"given":"Keon Wook","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2025.111867_bib1","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0140-6736(19)31894-X","article-title":"Acute liver failure","volume":"394","author":"Stravitz","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2025.111867_bib2","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jhep.2016.12.003","article-title":"EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure","volume":"66","author":"Wendon","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cbi.2025.111867_bib3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s13578-022-00921-4","article-title":"The immunological mechanisms and therapeutic potential in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity","volume":"12","author":"Li","year":"2022","journal-title":"Cell Biosci."},{"key":"10.1016\/j.cbi.2025.111867_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1053\/j.gastro.2010.05.018","article-title":"Innate immunity and steatohepatitis: a critical role of another toll (TLR-9)","volume":"139","author":"Gao","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cbi.2025.111867_bib5","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","article-title":"NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice","volume":"66","author":"Mridha","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cbi.2025.111867_bib6","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.cbi.2025.111867_bib7","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrgastro.2015.94","article-title":"Inflammasome activation and function in liver disease","volume":"12","author":"Szabo","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cbi.2025.111867_bib8","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/ni.2749","article-title":"Phosphorylation of the adaptor ASC acts as a molecular switch that controls the formation of speck-like aggregates and inflammasome activity","volume":"14","author":"Hara","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cbi.2025.111867_bib9","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2025.111867_bib10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.clim.2012.12.006","article-title":"Specific inflammasomes in complex diseases","volume":"147","author":"Masters","year":"2013","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.cbi.2025.111867_bib11","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","article-title":"Mechanism and regulation of NLRP3 inflammasome activation","volume":"41","author":"He","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.cbi.2025.111867_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011765","article-title":"Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation","volume":"5","author":"Rajamaki","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2025.111867_bib13","doi-asserted-by":"crossref","first-page":"17664","DOI":"10.1074\/jbc.M212723200","article-title":"Characterization of the MRP4- and MRP5-mediated transport of cyclic nucleotides from intact cells","volume":"278","author":"Wielinga","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2025.111867_bib14","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1124\/dmd.116.069468","article-title":"Cysteinyl leukotriene receptor 1\/2 antagonists nonselectively modulate organic anion transport by Multidrug Resistance Proteins (MRP1-4)","volume":"44","author":"Csandl","year":"2016","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2025.111867_bib15","doi-asserted-by":"crossref","first-page":"6979","DOI":"10.1074\/jbc.M110.166868","article-title":"Multidrug resistance protein 4 (MRP4\/ABCC4) regulates cAMP cellular levels and controls human leukemia cell proliferation and differentiation","volume":"286","author":"Copsel","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2025.111867_bib16","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1006\/bbrc.1995.1344","article-title":"The leukotriene LTD4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance","volume":"208","author":"Gekeler","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2025.111867_bib17","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1056\/NEJM199012203232504","article-title":"Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist","volume":"323","author":"Manning","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2025.111867_bib18","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.cmet.2019.08.001","article-title":"Glutamate signaling in hepatic stellate cells drives alcoholic steatosis","volume":"30","author":"Choi","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.cbi.2025.111867_bib19","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s12272-023-01474-x","article-title":"Role of monocarboxylate transporter I\/lactate dehydrogenase B-mediated lactate recycling in tamoxifen-resistant breast cancer cells","volume":"46","author":"Choi","year":"2023","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.cbi.2025.111867_bib20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12272-023-01438-1","article-title":"Anti-fibrotic effect of aurocyanide, the active metabolite of auranofin","volume":"46","author":"Kim","year":"2023","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.cbi.2025.111867_bib21","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1124\/dmd.112.049676","article-title":"Alcohol cirrhosis alters nuclear receptor and drug transporter expression in human liver","volume":"41","author":"More","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2025.111867_bib22","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00424-006-0054-9","article-title":"Multidrug resistance-associated proteins 3, 4, and 5","volume":"453","author":"Borst","year":"2007","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.cbi.2025.111867_bib23","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1124\/dmd.110.035873","article-title":"Similarities and differences in the expression of drug-metabolizing enzymes between human hepatic cell lines and primary human hepatocytes","volume":"39","author":"Guo","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2025.111867_bib24","doi-asserted-by":"crossref","first-page":"20828","DOI":"10.1074\/jbc.271.34.20828","article-title":"Elevated cyclic AMP inhibits NF-kappaB-mediated transcription in human monocytic cells and endothelial cells","volume":"271","author":"Ollivier","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2025.111867_bib25","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1074\/jbc.M113.525501","article-title":"NF-kappaB and enhancer-binding CREB protein scaffolded by CREB-binding protein (CBP)\/p300 proteins regulate CD59 protein expression to protect cells from complement attack","volume":"289","author":"Du","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2025.111867_bib26","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.immuni.2013.05.016","article-title":"K(+) efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter","volume":"38","author":"Munoz-Planillo","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.cbi.2025.111867_bib27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1074\/jbc.M110.139048","article-title":"Sodium overload and water influx activate the NALP3 inflammasome","volume":"286","author":"Schorn","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2025.111867_bib28","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.molcel.2012.11.009","article-title":"Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity","volume":"49","author":"Py","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cbi.2025.111867_bib29","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.immuni.2016.09.008","article-title":"Bile acids control inflammation and metabolic disorder through inhibition of NLRP3 inflammasome","volume":"45","author":"Guo","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.cbi.2025.111867_bib30","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.freeradbiomed.2013.08.178","article-title":"NLRP3 inflammasome activation in D-galactosamine and lipopolysaccharide-induced acute liver failure: role of heme oxygenase-1","volume":"65","author":"Kim","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2025.111867_bib31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mib.2012.11.008","article-title":"Inflammasomes and host defenses against bacterial infections","volume":"16","author":"Vladimer","year":"2013","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.cbi.2025.111867_bib32","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/emmm.201201771","article-title":"Of inflammasomes and pathogens--sensing of microbes by the inflammasome","volume":"5","author":"Bauernfeind","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.cbi.2025.111867_bib33","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/JLB.3MIR0919-191R","article-title":"Inflammasomes in the pathophysiology of autoinflammatory syndromes","volume":"107","author":"Tartey","year":"2020","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cbi.2025.111867_bib34","article-title":"The NLRP3 inflammasome in non-alcoholic fatty liver disease and steatohepatitis: therapeutic targets and treatment","volume":"13","author":"Yu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cbi.2025.111867_bib35","article-title":"Inflammasome and pyroptosis in autoimmune liver diseases","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cbi.2025.111867_bib36","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1172\/JCI35067","article-title":"Multidrug resistance-associated protein 4 regulates cAMP-dependent signaling pathways and controls human and rat SMC proliferation","volume":"118","author":"Sassi","year":"2008","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cbi.2025.111867_bib37","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1172\/JCI45023","article-title":"Inhibition of MRP4 prevents and reverses pulmonary hypertension in mice","volume":"121","author":"Hara","year":"2011","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cbi.2025.111867_bib38","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nature11588","article-title":"The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP","volume":"492","author":"Lee","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2025.111867_bib39","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.4049\/jimmunol.159.11.5450","article-title":"Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-kappaB-mediated transcription","volume":"159","author":"Parry","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.cbi.2025.111867_bib40","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1164\/ajrccm\/144.3_Pt_1.617","article-title":"MK-571, a potent antagonist of leukotriene D4-induced bronchoconstriction in the human","volume":"144","author":"Kips","year":"1991","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.cbi.2025.111867_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105030","article-title":"Blame the signaling: role of cAMP for the resolution of inflammation","volume":"159","author":"Tavares","year":"2020","journal-title":"Pharmacol. Res."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279725004971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279725004971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T22:38:00Z","timestamp":1777415880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279725004971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":41,"alternative-id":["S0009279725004971"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2025.111867","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of NOD-like receptor pyrin domain-containing protein 3 inflammasome activation by MK-571, a multidrug resistance protein inhibitor","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2025.111867","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111867"}}